Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ezetimibe Treatment Use in HoFH or Sitosterolemia
NCT00092833Phase 3Terminated
- Sponsor
- Organon & Co.
- Start
- Jul 2002
- Primary completion
- May 2005
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of ezetimibe in homozygous familial hypercholesterolemia (HoFH), sitosterolemia, sponsored by Organon & Co.. Started Jul 2002; status: terminated.
02
Drugs
ezetimibe
03
Conditions
homozygous familial hypercholesterolemia (HoFH)sitosterolemia
Beyond the preview
Go deeper on NCT00092833.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00092833.